Michael D Yarger

Title: **Michael D. Yarger: Innovator in Radioembolization Technology**

Introduction

Michael D. Yarger, based in Chapel Hill, North Carolina, is an accomplished inventor with a focus on advancements in medical technology. He holds a patent that significantly enhances the methodologies used in radioembolization, a procedure that is crucial for treating various forms of cancer.

Latest Patents

Yarger's notable patent is titled "Systems and methods for determining flow parameters of administered fluid from radioembolization delivery device." This innovation involves sophisticated approaches for assessing the flow rate and movement of fluids delivered by a radioembolization device. The patented technology incorporates a response mechanism involving translational movement of a delivery arm, integrated pattern sensors, and a processing unit to accurately determine flow characteristics, which can greatly improve therapeutic outcomes.

Career Highlights

Currently, Michael D. Yarger is affiliated with Bard Peripheral Vascular, Inc., where his expertise contributes to advancing vascular technologies. His background in engineering and research provides a strong foundation for his contributions in the field. With one patent to his name, he stands out as a key figure in the development of innovative medical devices.

Collaborations

Yarger collaborates with esteemed colleagues, including Adam Martin and Mircea Stefan Despa, who also contribute to the research and development initiatives at Bard Peripheral Vascular. These collaborations reflect a synergy of expertise aimed at creating effective solutions in vascular health technologies.

Conclusion

Michael D. Yarger exemplifies the quintessence of innovation within the medical device sector, particularly in radioembolization technology. Through his significant patent and collaborative efforts, he continues to make strides that benefit patient care and treatment methodologies.